Prominent Influenza Vaccines Market Trend for 2025: Adoption Of Technologically Advanced Vaccine Production Drives Growth In The Influenza Vaccine Market

How Are the key drivers contributing to the expansion of the influenza vaccines market?
The growing occurrences of seasonal flu are predicted to boost the upward trajectory of the influenza vaccine market. The term seasonal influenza is used to describe a respiratory disease induced by influenza viruses that commonly spread and cause infections during particular periods of the year, predominantly during colder months. This pattern is influenced by antigenic drift, susceptibility of the populace, environmental influences, insufficient vaccination distribution, and absence of widespread vaccination. Influenza vaccines aid in decreasing the occurrences of seasonal flu by offering immunity against the prevalent virus strains. For instance, in November 2023, the US government agency, Centers for Disease Control and Prevention (CDC) disclosed that during the 2022-2023 flu season, there were roughly 31 million flu-associated illnesses, 14 million flu-associated medial consultations, 360,000 flu-associated hospital admissions, and 21,000 flu-associated mortalities. Hence, the increasing incidences of influenza seasons are fueling the expansion of the influenza vaccines market.

Get Your Influenza Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

What growth opportunities are expected to drive the influenza vaccines market's CAGR through 2034?
In recent times, the influenza vaccines market has witnessed a robust growth. The size of this market would escalate from $7.35 billion in 2024 to $7.9 billion in 2025, showing a compound annual growth rate (CAGR) of 7.5%. Reasons contributing to the growth during the historical period include preparedness for pandemics, initiatives in public health, studies on vaccine efficiency, recommendations from healthcare professionals, and worldwide surveillance of influenza.

The market for influenza vaccines is predicted to experience robust expansion in the coming years, enlarging to $11.02 billion by 2029, with a compound annual growth rate (CAGR) of 8.7%. The anticipated surge in this timeframe is linked to environmental and climate factors, improvements in health care access, the emergence of novel influenza variants, advancements in adjuvants and delivery systems, and increased spending on health care. Key trends for this forecast period encompass increased application of mRNA vaccine technology, an emphasis on pediatric immunization, measures to manage seasonal influenza, improved immunization coverage in emerging economies, and customized vaccination strategies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What are the emerging trends shaping the future of the influenza vaccines market?
The increasing popularity of advanced vaccine production technology is a significant trend in the influenza vaccine market. Firms competing in this market are utilizing sophisticated vaccine production techniques to maintain their market standing. To illustrate, GlaxoSmithKline PLC., a British pharmaceutical and biotech firm, introduced the Multiple Antigen Presenting System (MAPS) for vaccine development in January 2023. This groundbreaking method offers a revolutionary approach to creating potent vaccines to battle infectious bacteria and viruses. Additionally, this technique is advantageous for swiftly developing vaccines during epidemic or pandemic episodes.

Which growth-oriented segments of the influenza vaccines market are leading the industry's development?
The influenza vaccines market covered in this report is segmented -

1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

What regions are leading the charge in the influenza vaccines market?
North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the influenza vaccines market?
Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What Is Covered In The Influenza Vaccines Global Market Report?

• Market Size Forecast: Examine the influenza vaccines market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the influenza vaccines market for a structured understanding.
• Key Players Overview: Analyze major players in the influenza vaccines market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the influenza vaccines market.
• Segment Contributions: Evaluate how different segments drive overall growth in the influenza vaccines market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the influenza vaccines market.
• Industry Challenges: Identify potential risks and obstacles affecting the influenza vaccines market.
• Competitive Landscape: Review strategic developments in the influenza vaccines market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.